Statements (78)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:project
|
| gptkbp:aims_to |
drug development
cancer treatment outcomes genetic mutations in cancer |
| gptkbp:analysis |
various cancer studies
|
| gptkbp:collaborated_with |
gptkb:National_Human_Genome_Research_Institute
pharmaceutical companies international research groups |
| gptkbp:collaborates_with |
academic institutions
|
| gptkbp:collaborations |
research institutions
multi-institutional project |
| gptkbp:contributed_to |
precision medicine
understanding of cancer heterogeneity |
| gptkbp:created |
cancer evolution
|
| gptkbp:data_usage |
over 11,000 tumor samples
|
| gptkbp:ends_at |
gptkb:2018
|
| gptkbp:facilitates |
genomic profiling
|
| gptkbp:focuses_on |
cancer genomics
|
| gptkbp:founded |
cancer therapies
|
| gptkbp:has_feature |
personalized medicine approaches
|
| gptkbp:has_impact_on |
cancer diagnostics
tumor markers |
| gptkbp:has_influence_on |
healthcare policies
cancer treatment resistance |
| gptkbp:has_written |
clinical trials
tumor microenvironment |
| https://www.w3.org/2000/01/rdf-schema#label |
The Cancer Genome Atlas
|
| gptkbp:is_accessible_by |
gptkb:Genomic_Data_Commons
|
| gptkbp:is_aleader_in |
genomic research
|
| gptkbp:is_aplace_for |
genomic analysis
|
| gptkbp:is_aresource_for |
oncologists
pharmaceutical research molecular oncology genomic epidemiology public health researchers |
| gptkbp:is_associated_with |
biobanks
|
| gptkbp:is_informed_by |
bioinformatics
|
| gptkbp:is_involved_in |
translational research
data integration efforts |
| gptkbp:is_part_of |
gptkb:National_Cancer_Moonshot_Initiative
global cancer initiatives cancer genomics initiatives |
| gptkbp:is_recognized_by |
gptkb:Research_Institute
|
| gptkbp:is_recognized_for |
data sharing practices
|
| gptkbp:is_studied_in |
multiple cancer types
|
| gptkbp:is_supported_by |
non-profit organizations
|
| gptkbp:is_used_by |
researchers worldwide
|
| gptkbp:is_utilized_in |
drug discovery
clinical research biomedical researchers clinical applications |
| gptkbp:launched |
gptkb:healthcare_organization
gptkb:2006 |
| gptkbp:leadership |
large-scale genomic projects
|
| gptkbp:led_to |
improved cancer therapies
new therapeutic targets |
| gptkbp:produced_by |
large-scale genomic data
|
| gptkbp:provides |
data for biomarker discovery
|
| gptkbp:provides_information_on |
clinical trials
cancer research cancer progression tumor biology |
| gptkbp:publishes |
over 1,000 scientific papers
|
| gptkbp:receives_funding_from |
gptkb:U._S._government
|
| gptkbp:research |
cancer prevention strategies
rare cancers tumor immunology cancer biomarkers tumor genetics |
| gptkbp:technology |
high-throughput sequencing
|
| gptkbp:was_akey_figure_in |
cancer research
genomic data genomic medicine cancer research community cancer research infrastructure |
| gptkbp:bfsParent |
gptkb:Bert_Vogelstein
gptkb:Broad_Institute |
| gptkbp:bfsLayer |
5
|